Publications by authors named "Ali Nasrollahizadeh"
Aims: Cardiovascular diseases (CVD) are a leading cause of mortality and morbidity in the North Africa and Middle East (NAME) region. Due to the paucity of research on this issue, we aimed to estimate the burden of CVD and its attributable risk factors in the NAME region.
Methods And Results: Data from the Global Burden of Disease (GBD) were retrieved to estimate the incidence, prevalence, deaths, years of life lost, years lived with disability, disability-adjusted life years (DALYs) for CVD across 21 countries and both sexes.
Different interventions have been evaluated for the treatment of depression in heart failure (HF) patients. However, clear and established recommendations are lacking. PubMed, Scopus, and Web of Science databases were systematically searched for randomized controlled trials (RCT) evaluating the effect of various treatment options on depression scores in heart failure patients.
View Article and Find Full Text PDFArticle Synopsis
- Pulmonary arterial hypertension (PAH) affects about 1% of the global population, especially older adults, and managing it has evolved significantly with various treatment strategies.
- Sotatercept, an FDA-approved drug, shows promise in treating PAH, but its safety and effectiveness are not well understood.
- A recent meta-analysis found that Sotatercept improved pulmonary vascular resistance and patient functionality compared to a placebo, with similar adverse events in both groups, but it significantly increased hemoglobin levels, highlighting the need for further research on its effects on anemia in PAH patients.
Background: Blood sugar (BS) has been proposed as a prognostic factor for COVID-19. In this historical cohort study we evaluated the association between admission time BS and COVID-19 outcome.
Methods: First, hospitalized COVID-19 patients were divided into three groups; Non-diabetic patients with BS < 140 mg/dl (N = 394), non-diabetic patients with BS ≥ 140 mg/dl (N = 113) and diabetic patients (N = 315).